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Bronchial Asthma (BA) should be controlled with the 
using of the basic therapy, according to Global initiative 
for asthma (GINA) report. But, the clinical statistics 
show us that this treatment is effective only in 60% 
school-age children with BA. That’s why the main aim 
of our study is to increase effectiveness of BA treatment 
by Nucleinate using in the complex anti-inflammatory 
therapy. 98-school-age children with BA in the remission 
period were subjected to complex examination by 
double blind, randomised, placebo controlled method. 
They were divided into two groups. The 1st clinical 
group consisted of 47 patients who were adminstered 
Nucleinate in the dose of 0.25g/day for 21 days in basic 
therapy complex. The 2nd clinical group consisted of 51 
patients whom placebo was adminstered with the same 
scheme. The groups didn’t vary significantly in main 
parameters and signs. For determination hypersensitivity 
of respiratory tract (HSRT), it was estimated by the 
findings of an inducing dose of histamine, which resulted 
in a 20% reduction of FEV1 (PC20H), and a cumulative 
dose (PD20Н) with the use of histamine serial dilution. 
Besides that, there were calculated the absolute risk 
(AR), relative risk (RR) and odds ratio (OR) of event in 
the 1st group of children to patients from control group 
with 95% (Conjitence Interval). The effectiveness of the 
basic treatment was analyzed with next indexes: decrease 
of absolute risk (DAR), relative risk (DRR) and the 
minimum number of the patient which should be treated to 
have one positive result (MNT). Results and Discussion: 
Clinical and epidemiological risk indicators, registering 
lower bronchial hypersensitivity were as follows: AR - 
0,3; RR - 1,9 (95% CІ 1,3-9,3) and OR - 3,3 (95% CІ 
1,7-6,1). The use of Nucleinate in the basic therapy of 
the school-age children significantly reduced the risk 
of preserving expressed by bronchial hypersensitivity: 
DAR – 25,8%, DRR – 54,8% (95% CІ 44,5-64,8), MNT 
– 1,8 (95% CІ 0,1-7,1). Thus, the results of the use of 
Nucleinate in the combined therapy in the BA treatment 
in school-age children shows a significant reduction in 
HRST, except that the positive result after our treatment 
is present in every second child. Doctors should give 
Nucleinate in dose 0,25 g per day in the complex therapy 
of BA in school-age children without control due to 
severe bronchial hypersensitivity.
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Gestational diabetes mellitus (GDM), defined as 
carbohydrate intolerance of variable severity with onset 
or first recognition during the present pregnancy. GDM is 
the subject of interest not only for endocrinologists, but 
also for obstetricians-gynecologists and neonatologists, 
as this pathology is associated with numerous obstetric 
complications, high rate of perinatal morbidity and 
mortality. Active screening of GDM gives the opportunity 
to establish the groups of risk for DM development 
among female population and to provide direct preventive 
measures. 
Objective of the research was to study carbohydrate 
metabolism in pregnant women for screening and 
diagnistics of gestational diabetes. 
To accomplish this, 131 pregnant women, considering 
to have the risk of DM or demonstrating the level of 
fasting glycemia higher than 5,0 mmol/l in capillary blood 
(or higher than 5,83 mmol/l in blood plasma) on their 
examination in women’s consulting centers or prenatal 
clinics, were included into this study. The 2-step system 
was used for assessement of carbohydrate metabolism. 
1-hour 50g glucose tolerance test (GTT) was performed 
as screening, followed by 3-hour GTT for those with an 
abnormal screening results (if glycemia level exceeded 
7,8 mmol/l).
Results. According to the results of first step of the 
research, glucose intolerance was diagnosed in 48% of 
women, who continued participation in the study. 3-hour 
GTT revealed that in 38 women (60%) glycemia level 
exceeded threshold value (5,72±0,123 mmol/l) and their 
1-hour postprandial glycemia increased more significantly 
(to 7,36±0,280 mmol/l) as compared with the rest of 
pregnant women (Р<0,001), their 2-hour postprandial 
glucose level decreased to 6,33±0,254 mmol/l, still 
remaining higher as compared with fasting glycemia level 
(Р<0,001). Only 3-hour postprandial glycemia level was 
similar to fasting one, but higher than corresponding index 
in healthy pregnant women (Р<0,001). It’s important to 
note, that 1-hour as well as 2-hour postprandial glucose 
level was the highest in women during I trimester of 
pregnancy. 3-hour postprandial glycemia level in women 
during late terms of gestation significantly exceeded 
that index healthy pregnant women. Thus, in 7 cases, 
diagnosed as GDM, 2 examined women (29%) were 
during I pregnancy trimester, and 5 of them (71%) – 
during II pregnancy trimester.
Conclusion. The results of present research show, that 
the disturbance of carbohydrate metabolism of variable 
severity is revealed approximately in 48% pregnant 
women during their examination by endocrinologist, 
and in 5% of women GDM is diagnosed. Screening of 
carbohydrate intolerance in pregnant women is extremely 
important for early diagtostics and treatment of the 
diseases, influencing the growth of the developing fetus, 
clinical course of a pregnancy and labor.
